Jerome L. Shupack

4.0k total citations
79 papers, 2.7k citations indexed

About

Jerome L. Shupack is a scholar working on Dermatology, Immunology and Epidemiology. According to data from OpenAlex, Jerome L. Shupack has authored 79 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Dermatology, 22 papers in Immunology and 21 papers in Epidemiology. Recurrent topics in Jerome L. Shupack's work include Psoriasis: Treatment and Pathogenesis (16 papers), Autoimmune Bullous Skin Diseases (10 papers) and Nail Diseases and Treatments (9 papers). Jerome L. Shupack is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (16 papers), Autoimmune Bullous Skin Diseases (10 papers) and Nail Diseases and Treatments (9 papers). Jerome L. Shupack collaborates with scholars based in United States, Switzerland and Guatemala. Jerome L. Shupack's co-authors include Matthew J. Stiller, Miriam Keltz Pomeranz, Ken Washenik, Kenneth Washenik, John Koo, Michael L. Reed, Kimberly Siu, Norman Levine, Richard P. Haydey and LEONARD M. DZUBOW and has published in prestigious journals such as New England Journal of Medicine, JAMA and Neurology.

In The Last Decade

Jerome L. Shupack

77 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerome L. Shupack United States 29 1.1k 698 646 419 337 79 2.7k
P.E. Hutchinson United Kingdom 31 1.3k 1.2× 587 0.8× 919 1.4× 502 1.2× 347 1.0× 83 3.0k
Joseph G. Morelli United States 31 1.4k 1.3× 591 0.8× 411 0.6× 492 1.2× 893 2.6× 122 3.7k
V. Descamps France 29 672 0.6× 593 0.8× 646 1.0× 373 0.9× 245 0.7× 165 3.0k
Ortonne Jp France 32 1.4k 1.3× 324 0.5× 1.3k 2.0× 315 0.8× 649 1.9× 133 3.0k
Charles Camisa United States 28 757 0.7× 578 0.8× 399 0.6× 317 0.8× 313 0.9× 116 2.7k
Maxwell A. Fung United States 23 838 0.8× 692 1.0× 637 1.0× 351 0.8× 99 0.3× 125 2.3k
Eduardo Fonseca Spain 27 903 0.8× 680 1.0× 686 1.1× 569 1.4× 138 0.4× 256 3.0k
Amrinder J. Kanwar India 30 1.2k 1.1× 399 0.6× 331 0.5× 157 0.4× 731 2.2× 156 2.7k
Klaus Degitz Germany 31 1.2k 1.1× 498 0.7× 690 1.1× 586 1.4× 347 1.0× 81 3.0k
Motonobu Nakamura Japan 29 872 0.8× 249 0.4× 1.0k 1.6× 748 1.8× 239 0.7× 184 3.4k

Countries citing papers authored by Jerome L. Shupack

Since Specialization
Citations

This map shows the geographic impact of Jerome L. Shupack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerome L. Shupack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerome L. Shupack more than expected).

Fields of papers citing papers by Jerome L. Shupack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerome L. Shupack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerome L. Shupack. The network helps show where Jerome L. Shupack may publish in the future.

Co-authorship network of co-authors of Jerome L. Shupack

This figure shows the co-authorship network connecting the top 25 collaborators of Jerome L. Shupack. A scholar is included among the top collaborators of Jerome L. Shupack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerome L. Shupack. Jerome L. Shupack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hunt, Raegan, et al.. (2010). Familial benign chronic pemphigus (Hailey-Hailey disease). Dermatology Online Journal. 16(11). 14–14. 12 indexed citations
2.
Strober, Bruce, Kimberly Siu, Andrew Alexis, et al.. (2005). Etanercept does not effectively treat moderate to severe alopecia areata: An open-label study. Journal of the American Academy of Dermatology. 52(6). 1082–1084. 81 indexed citations
3.
Duvic, Madeleine, Elise A. Olsen, George Omura, et al.. (2001). A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma. Journal of the American Academy of Dermatology. 44(6). 940–947. 25 indexed citations
4.
Gilson, Richard, Jerome L. Shupack, Alvin E. Friedman‐Kien, et al.. (1999). A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. AIDS. 13(17). 2397–2404. 65 indexed citations
5.
Brancaccio, Ronald R., et al.. (1998). Six-Hour Versus 48-Hour Patch Testing With Varying Concentrations of Potassium Dichromate. Dermatitis. 9(2). 92–95. 3 indexed citations
6.
Shupack, Jerome L., Elizabeth Abel, Eugene A. Bauer, et al.. (1997). Cyclosporine as maintenance therapy in patients with severe psoriasis. Journal of the American Academy of Dermatology. 36(3). 423–432. 78 indexed citations
7.
Shupack, Jerome L.. (1997). Maintenance therapy with Neoral®. International Journal of Dermatology. 36(s1). 34–36. 3 indexed citations
8.
Washenik, Kenneth, et al.. (1996). Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential uses. Journal of the American Academy of Dermatology. 35(6). 969–979. 264 indexed citations
9.
Stiller, Matthew J., et al.. (1994). Primary cutaneous infection by Aspergillus ustus in a 62-year-old liver transplant recipient. Journal of the American Academy of Dermatology. 31(2). 344–347. 56 indexed citations
10.
Stiller, Matthew J., et al.. (1993). Three-dimensional imaging for diagnostic ultrasound in dermatology. Journal of the American Academy of Dermatology. 29(2). 171–175. 17 indexed citations
11.
Stiller, Matthew J., Jerome L. Shupack, & Stanley A. Rosenthal. (1993). TREATMENT OE DERMATOPHYTOSES II: NEWER TOPICAL ANTIEUNGAL DRUGS. International Journal of Dermatology. 32(9). 638–641. 1 indexed citations
12.
Stiller, Matthew J., et al.. (1993). Antibody titers to an oxidized thymidine moiety are altered by systemic pharmacotherapy and by ultraviolet B phototherapy. Archives of Dermatological Research. 285(4). 227–229. 9 indexed citations
13.
Frenkel, Krystyna, et al.. (1992). Enhanced antibody titers to an oxidized DNA base in inflammatory and neoplastic diseases. Experimental Dermatology. 1(5). 242–247. 18 indexed citations
14.
Stiller, Matthew J., et al.. (1992). A CONCISE GUIDE TO TOPICAL SUNSCREENS: STATE OF THE ART. International Journal of Dermatology. 31(8). 540–543. 4 indexed citations
15.
Shupack, Jerome L., et al.. (1992). Decreased Peripheral Blood Eosinophil Counts in Severe Psoriatic Patients Treated with Low-Dose Cyclosporine A. Dermatology. 185(3). 202–204. 9 indexed citations
16.
Berman, Brian, Charles N. Ellis, William D. James, et al.. (1992). Efficacy of a 1-week, twice-daily regimen of terbinafine 1 % cream in the treatment of interdigital tinea pedis. Journal of the American Academy of Dermatology. 26(6). 956–960. 55 indexed citations
17.
Shupack, Jerome L., Matthew J. Stiller, & Robert S. Haber. (1991). Psoriasis and Reiter's syndrome. Clinics in Dermatology. 9(1). 53–IN12. 17 indexed citations
18.
Shupack, Jerome L., et al.. (1989). Ocular Side Effects of the Retinoids. International Journal of Dermatology. 28(4). 218–225. 18 indexed citations
19.
Camuto, Patricia M., et al.. (1987). Long-Term Effects of Etretinate on the Liver in Psoriasis. The American Journal of Surgical Pathology. 11(1). 30–37. 33 indexed citations
20.
Weitzman, Irene, Stanley A. Rosenthal, & Jerome L. Shupack. (1985). A comparison betweenDactylaria gallopavaandScoleocobasidium humicola: first report of an infection in a tortoise caused byS. humicola. Medical Mycology. 23(4). 287–293. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026